Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 346
Healthy volunteers: no

Brief summary:
This trial is conducted in Africa, Asia, Europe and North America. The purpose of the trial is to investigate the effect of insulin degludec (IDeg) in combination with liraglutide (Lira) and metformin (at least 1500 mg daily or maximum tolerated dose) in subjects with type 2 diabetes qualifying for treatment intensification.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: insulin degludec intervention 2: placebo intervention 3: liraglutide
Intervention descriptions: intervention 1: Administered s.c. (under the skin) once daily. Dose individually adjusted. intervention 2: Administered s.c. (under the skin) once daily. Dose individually adjusted. intervention 3: Administered s.c. (under the skin) once daily. Dose: 1.8 mg.

Protocol document: